Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
DeLand, FL
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Fort Meyers, FL
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Jupiter, FL
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Louisville, KY
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Peabody, MA
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Peabody, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Kalamazoo, MI
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Saginaw, MI
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Saginaw, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Berlin, NJ
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Berlin, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Research Site
mi
from
Dover, NJ
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Research Site
mi
from
Dover, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Rochester, NY
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Cincinnati, OH
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Cleveland, OH
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Franklin, OH
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Franklin, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Bethany, OK
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Bethany, OK
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Duncansville, PA
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Penndel, PA
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Penndel, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Warwick, RI
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Anderson, SC
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Columbia, SC
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Kingsport, TN
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Austin, TX
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
mi
from
Nederland, TX
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
mi
from
Nederland, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Clinical Research Facility
mi
from
Newport News, VA
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Clinical Research Facility
mi
from
Newport News, VA
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated:  2/19/2009
Research Site
mi
from
Burnaby,
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Research Site
mi
from
Burnaby,
Click here to add this to my saved trials
Perioperative Intervention to Improve Post-TKR Support and Function
Perioperative Intervention to Improve Post-TKR Support and Function
Status: Enrolling
Updated:  3/31/2009
University of Massachusetts Memorial Health Center; Arthritis and Total Joint Center
mi
from
Worcester, MA
Perioperative Intervention to Improve Post-TKR Support and Function
Perioperative Intervention to Improve Post-TKR Support and Function
Status: Enrolling
Updated: 3/31/2009
University of Massachusetts Memorial Health Center; Arthritis and Total Joint Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Investigating the Impact of Mode of Administration on Item Response
Investigating the Impact of Mode of Administration on Item Response
Status: Enrolling
Updated:  4/7/2009
Polimetrix
mi
from
Palo Alto, CA
Investigating the Impact of Mode of Administration on Item Response
Investigating the Impact of Mode of Administration on Item Response
Status: Enrolling
Updated: 4/7/2009
Polimetrix
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Investigating the Impact of Mode of Administration on Item Response
Investigating the Impact of Mode of Administration on Item Response
Status: Enrolling
Updated:  4/7/2009
Rheumatology Associates of Long Island
mi
from
Port Jefferson, NY
Investigating the Impact of Mode of Administration on Item Response
Investigating the Impact of Mode of Administration on Item Response
Status: Enrolling
Updated: 4/7/2009
Rheumatology Associates of Long Island
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)
Consortium for the Longitudinal Evaluation of African-Americans With Early Rheumatoid Arthritis (CLEAR) Registry
Status: Enrolling
Updated:  5/5/2009
University of Alabama at Birmingham
mi
from
Birmingham, AL
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)
Consortium for the Longitudinal Evaluation of African-Americans With Early Rheumatoid Arthritis (CLEAR) Registry
Status: Enrolling
Updated: 5/5/2009
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Coping Skills Training for Arthritis: An Effectiveness Trial
Status: Enrolling
Updated:  6/5/2009
Stony Brook Primary Care
mi
from
Setauket, NY
Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Coping Skills Training for Arthritis: An Effectiveness Trial
Status: Enrolling
Updated: 6/5/2009
Stony Brook Primary Care
mi
from
Setauket, NY
Click here to add this to my saved trials
Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Coping Skills Training for Arthritis: An Effectiveness Trial
Status: Enrolling
Updated:  6/5/2009
Rheumatology Associates of Long Island
mi
from
Port Jefferson, NY
Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Coping Skills Training for Arthritis: An Effectiveness Trial
Status: Enrolling
Updated: 6/5/2009
Rheumatology Associates of Long Island
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Coping Skills Training for Arthritis: An Effectiveness Trial
Status: Enrolling
Updated:  6/5/2009
Piedmont Primary Care
mi
from
Danville, VA
Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain
Coping Skills Training for Arthritis: An Effectiveness Trial
Status: Enrolling
Updated: 6/5/2009
Piedmont Primary Care
mi
from
Danville, VA
Click here to add this to my saved trials
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants
Status: Enrolling
Updated:  11/6/2009
University of Pittsburgh - Oakland Falk Clinic
mi
from
Pittsburgh, PA
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants
Status: Enrolling
Updated: 11/6/2009
University of Pittsburgh - Oakland Falk Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy
Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy
Status: Enrolling
Updated:  12/11/2009
Walter Reed Army Medical Center
mi
from
Washington,
Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy
Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy
Status: Enrolling
Updated: 12/11/2009
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity
Gene-Environment Interactions in RA Autoimmunity Disease Severity
Status: Enrolling
Updated:  1/11/2010
Omaha Veteran Medical Center
mi
from
Omaha, NE
Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity
Gene-Environment Interactions in RA Autoimmunity Disease Severity
Status: Enrolling
Updated: 1/11/2010
Omaha Veteran Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Iyengar Yoga for Young People With Rheumatoid Arthritis
Iyengar Yoga for Young People With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/30/2010
UCLA Pediatric Pain Program Research Offices
mi
from
Los Angeles, CA
Iyengar Yoga for Young People With Rheumatoid Arthritis
Iyengar Yoga for Young People With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/30/2010
UCLA Pediatric Pain Program Research Offices
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness Study of Hyaluronic Acid for Osteoarthritis of the Knee
Status: Enrolling
Updated:  6/21/2010
Resurgens Orthopedics
mi
from
Cumming, GA
Safety and Effectiveness Study of Hyaluronic Acid for Osteoarthritis of the Knee
Status: Enrolling
Updated: 6/21/2010
Resurgens Orthopedics
mi
from
Cumming, GA
Click here to add this to my saved trials
Curcumin in Rheumatoid Arthritis
Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study
Status: Enrolling
Updated:  7/1/2010
Swamy Venuturpualli, M.D., 8737 Beverly Blvd., #203
mi
from
Beverly Hills, CA, CA
Curcumin in Rheumatoid Arthritis
Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study
Status: Enrolling
Updated: 7/1/2010
Swamy Venuturpualli, M.D., 8737 Beverly Blvd., #203
mi
from
Beverly Hills, CA, CA
Click here to add this to my saved trials
Curcumin in Rheumatoid Arthritis
Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study
Status: Enrolling
Updated:  7/1/2010
UCLA, 1000 Veteran Avenue, Rehab Building, 3rd Floor
mi
from
Los Angeles, CA
Curcumin in Rheumatoid Arthritis
Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study
Status: Enrolling
Updated: 7/1/2010
UCLA, 1000 Veteran Avenue, Rehab Building, 3rd Floor
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
Status: Enrolling
Updated:  9/7/2010
The Center for Rheumatic Disease, Allergy and Immunology
mi
from
Kansas City, MO
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
Status: Enrolling
Updated: 9/7/2010
The Center for Rheumatic Disease, Allergy and Immunology
mi
from
Kansas City, MO
Click here to add this to my saved trials
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Status: Enrolling
Updated:  9/23/2010
NYU Hospital for Joint Diseases
mi
from
New York, NY
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 9/23/2010
NYU Hospital for Joint Diseases
mi
from
New York, NY
Click here to add this to my saved trials
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Status: Enrolling
Updated:  9/23/2010
Bellevue Hospital
mi
from
New York, NY
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Status: Enrolling
Updated: 9/23/2010
Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
Opioids Versus Extra Strength Acetaminophen for the Management of Moderate Persistent Non-cancer Pain
Status: Enrolling
Updated:  12/21/2010
University of Chicago Medical Center Outpatient Senior Health Center South Shore
mi
from
Chicago, IL
Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
Opioids Versus Extra Strength Acetaminophen for the Management of Moderate Persistent Non-cancer Pain
Status: Enrolling
Updated: 12/21/2010
University of Chicago Medical Center Outpatient Senior Health Center South Shore
mi
from
Chicago, IL
Click here to add this to my saved trials
Use of Thermal and 3D Imaging to Quantify Arthritis
Use of Thermal and 3D Imaging to Quantify Arthritis
Status: Enrolling
Updated:  2/16/2011
University of Pittsburgh
mi
from
Pittsburgh, PA
Use of Thermal and 3D Imaging to Quantify Arthritis
Use of Thermal and 3D Imaging to Quantify Arthritis
Status: Enrolling
Updated: 2/16/2011
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
A Self-Administered Questionnaire for Early Detection of Axial Spondyloarthritis
Status: Enrolling
Updated:  2/28/2011
Stanford University
mi
from
Stanford, CA
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
A Self-Administered Questionnaire for Early Detection of Axial Spondyloarthritis
Status: Enrolling
Updated: 2/28/2011
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans
RA Comorbidity: Bone Health in Men and African Americans
Status: Enrolling
Updated:  3/1/2011
Omaha VA Medical Center
mi
from
Omaha, NE
Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans
RA Comorbidity: Bone Health in Men and African Americans
Status: Enrolling
Updated: 3/1/2011
Omaha VA Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans
RA Comorbidity: Bone Health in Men and African Americans
Status: Enrolling
Updated:  3/1/2011
Omaha Veterans Affairs Medical Center
mi
from
Omaha, NE
Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans
RA Comorbidity: Bone Health in Men and African Americans
Status: Enrolling
Updated: 3/1/2011
Omaha Veterans Affairs Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
The Impact of Thumb Carpometacarpal Osteoarthritis on General Health
The Impact of Thumb Carpometacarpal Osteoarthritis on General Health
Status: Enrolling
Updated:  3/14/2011
Barnes Jewish Hospital
mi
from
St Louis, MO
The Impact of Thumb Carpometacarpal Osteoarthritis on General Health
The Impact of Thumb Carpometacarpal Osteoarthritis on General Health
Status: Enrolling
Updated: 3/14/2011
Barnes Jewish Hospital
mi
from
St Louis, MO
Click here to add this to my saved trials
Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis
Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis
Status: Enrolling
Updated:  4/4/2011
Omaha Veteran Medical Center
mi
from
Omaha, NE
Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis
Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis
Status: Enrolling
Updated: 4/4/2011
Omaha Veteran Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of PENNSAID Gel in the Treatment of Osteoarthritis of the Knee
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Clinical Study to Evaluate the Safety and Efficacy of PENNSAID Gel in the Symptomatic Treatment of Osteoarthritis of the Knee
Status: Enrolling
Updated:  4/20/2011
Genova Clinical Research
mi
from
Tucson, AZ
Evaluation of the Safety and Efficacy of PENNSAID Gel in the Treatment of Osteoarthritis of the Knee
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Clinical Study to Evaluate the Safety and Efficacy of PENNSAID Gel in the Symptomatic Treatment of Osteoarthritis of the Knee
Status: Enrolling
Updated: 4/20/2011
Genova Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials